iQflow, Public Subscription Competition Rate 686.71 to 1... Scheduled to be Listed on KOSDAQ on the 14th

Record competition rate of 686.71 to 1... Subscription deposit approximately 1.8267 trillion KRW
Scheduled to be listed on the KOSDAQ market on the 14th

[Asia Economy Reporter Eunmo Koo] IoFlow, a wearable drug delivery solution specialist company, announced on the 7th that it recorded a final subscription competition rate of 686.71 to 1 after conducting a public offering subscription for listing on the KOSDAQ market. IoFlow is scheduled to be listed on the KOSDAQ market on the 14th.

IoFlow conducted a public offering subscription for general investors over two days from the 3rd to the 4th, recording a competition rate of 686.71 to 1, and the general subscription deposit was estimated at approximately 1.8267 trillion KRW. Previously, the final public offering price was set at 19,000 KRW during the demand forecast for institutional investors held on the 27th and 28th of last month.

An IoFlow official explained, "While proceeding with the listing process, we made efforts to promote IoFlow’s unique core technology in the rapidly growing wearable insulin pump market and the direct benefits from the expansion of the insulin infusion device market,” adding, “As a result, many investors gave positive evaluations of IoFlow’s business competitiveness and future growth potential."

Jaejin Kim, CEO of IoFlow, said, "This KOSDAQ listing is expected to be a turning point for IoFlow to leap higher,” and added, “Starting with exports to Menarini in Europe within this year, we will expand our entry into global markets such as the United States and the Middle East, continue to expand non-diabetes product lines, and grow continuously to become a leading company in wearable drug delivery solutions."

This content was produced with the assistance of AI translation services.